You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API gabapentin


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing gabapentin

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Parke-Davis Div of Pfizer Inc NEURONTIN gabapentin 0071-0803 FD&C BLUE NO. 2
Parke-Davis Div of Pfizer Inc NEURONTIN gabapentin 0071-0803 GELATIN
Parke-Davis Div of Pfizer Inc NEURONTIN gabapentin 0071-0803 LACTOSE
Parke-Davis Div of Pfizer Inc NEURONTIN gabapentin 0071-0803 STARCH, CORN
Parke-Davis Div of Pfizer Inc NEURONTIN gabapentin 0071-0803 TALC
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for gabapentin

Excipient focus: 1,3-PROPANEDIOL BIS(4-AMINOBENZOATE)

Excipient focus: ACESULFAME POTASSIUM

Excipient focus: ACETIC ACID

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM HYDROXIDE

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: ANISE

Excipient focus: BROWN IRON OXIDE

Excipient focus: BUTYL ALCOHOL

Excipient focus: CALCIUM CARBONATE

Excipient focus: CALCIUM STEARATE

Excipient focus: CALCIUM SULFATE DIHYDRATE

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CI 77891

Excipient focus: COPOVIDONE

Excipient focus: COPOVIDONE K25-31

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C RED NO. 33

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: DEHYDRATED ALCOHOL

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL BEHENATE

Excipient focus: GLYCERYL DIBEHENATE

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: METHYLPARABEN

Excipient focus: N-BUTYL ALCOHOL

Excipient focus: POLOXAMER 407

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 7000000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POTASSIUM SORBATE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K90

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SACCHARIN SODIUM

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM ACETATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: STRAWBERRY

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: VP/VA COPOLYMER

Excipient focus: WATER

Excipient focus: XYLITOL

Excipient focus: ZEA MAYS

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group